Mohamed S A Elsayed

6PUBLICATIONS
34CO-AUTHORS
Gene and molecular therapyCheminformatics and quantitative structure-activity relationshipsMolecular targetsOrganometallic chemistry
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Aug 01, 2024
Discovery of Pyrazolopyrazines as Selective, Potent, and Mutant-Active MET Inhibitors with Intracranial Efficacy.

Quinn A Bumpers, Robert W Pipal, Anna M Benz-Weeden

|Dec 20, 2023
Discovery of 5-Azaquinoxaline Derivatives as Potent and Orally Bioavailable Allosteric SHP2 Inhibitors.

Mohamed S A Elsayed, James F Blake, Mark L Boys

|Jun 03, 2023
SHP2 Inhibition Sensitizes Diverse Oncogene-Addicted Solid Tumors to Re-treatment with Targeted Therapy.

Alexander Drilon, Manish R Sharma, Melissa L Johnson

|Jul 09, 2019
Indenoisoquinoline Topoisomerase Inhibitors Strongly Bind and Stabilize the MYC Promoter G-Quadruplex and Downregulate MYC.

Kai-Bo Wang, Mohamed S A Elsayed, Guanhui Wu

|Nov 22, 2018
Application of Sequential Palladium Catalysis for the Discovery of Janus Kinase Inhibitors in the Benzo[ c]pyrrolo[2,3- h][1,6]naphthyridin-5-one (BPN) Series.

Mohamed S A Elsayed, Jeffery J Nielsen, Sungtae Park

|Aug 14, 2018
Synthesis of Benzo[1,6]naphthyridinones Using the Catellani Reaction.

Mohamed S A Elsayed, Brittany Griggs, Mark Cushman

Pageof 1

Frequent Collaborators

3 joint publications

Ronald J Hinklin

2 joint publications

Mark Cushman

2 joint publications

Nickolas A Neitzel

1 joint publications

Dean Kahn